Literature DB >> 9593026

T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium.

R El Ridi1, F Farouk, M Sherif, M Al-Sherbiny, A Osman, N El Gengehi, C B Shoemaker.   

Abstract

Egyptian subjects living in areas endemic for Schistosoma mansoni or Schistosoma haematobium were selected on the basis of their apparent extremes of resistance or susceptibility to schistosomiasis and examined for T and B cell responses against the major electrophoretically resolved protein species from soluble adult worm extracts. A 42-kDa band was specifically recognized by a significant majority of subjects resistant to schistosomiasis. The 42-kDa species (p-42) from S. mansoni and S. haematobium were immunologically cross-reactive and induced significant protection in mice and hamsters against infection with cercariae. Amino acid sequence analysis of S. mansoni p-42 showed that it consists predominantly of glyceraldehyde 3-P dehydrogenase (G3PDH), which has been shown to be preferentially recognized by the sera of Brazilian subjects resistant to schistosomiasis mansoni. The present data extend the previous findings and imply that S. mansoni-derived G3PDH represents a target of protective T and B cell-mediated antischistosomiasis immunity in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593026     DOI: 10.1086/515274

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy.

Authors:  R El Ridi; C B Shoemaker; F Farouk; N H El Sherif; A Afifi
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection.

Authors:  Lucia A de Oliveira Fraga; Erika W Lamb; Elizabeth C Moreno; Mitali Chatterjee; Jan Dvořák; Melaine Delcroix; Mohammed Sajid; Conor R Caffrey; Stephen J Davies
Journal:  BMC Immunol       Date:  2010-11-15       Impact factor: 3.615

4.  Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine.

Authors:  Hatem Tallima; John P Dalton; Rashika El Ridi
Journal:  Front Immunol       Date:  2015-03-23       Impact factor: 7.561

Review 5.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

6.  Efficacy and safety of arachidonic acid for treatment of school-age children in Schistosoma mansoni high-endemicity regions.

Authors:  Rashida Barakat; Nadia E Abou El-Ela; Soraya Sharaf; Ola El Sagheer; Sahar Selim; Hatem Tallima; Maaike J Bruins; Kevin B Hadley; Rashika El Ridi
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

7.  Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni.

Authors:  Michael R Gatlin; Carla L Black; Pauline N Mwinzi; W Evan Secor; Diana M Karanja; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03

8.  Is arachidonic acid an endoschistosomicide?

Authors:  Violette Said Hanna; Azza Gawish; Marwa Abou El-Dahab; Hatem Tallima; Rashika El Ridi
Journal:  J Adv Res       Date:  2018-01-10       Impact factor: 10.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.